R Douglas Norby - Net Worth and Insider Trading
R Douglas Norby Net Worth
The estimated net worth of R Douglas Norby is at least $8 Million dollars as of 2024-11-13. R Douglas Norby is the Director of Alexion Pharmaceuticals Inc and owns about 32,481 shares of Alexion Pharmaceuticals Inc (ALXN) stock worth over $6 Million. R Douglas Norby is also the Director of Krystal Biotech Inc and owns about 9,000 shares of Krystal Biotech Inc (KRYS) stock worth over $2 Million. Details can be seen in R Douglas Norby's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that R Douglas Norby has not made any transactions after 2018-05-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of R Douglas Norby
R Douglas Norby Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, R Douglas Norby owns 5 companies in total, including Krystal Biotech Inc (KRYS) , Alexion Pharmaceuticals Inc (ALXN) , and MagnaChip Semiconductor Corp (MX) among others .
Click here to see the complete history of R Douglas Norby’s form 4 insider trades.
Insider Ownership Summary of R Douglas Norby
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KRYS | Krystal Biotech Inc | 2018-05-09 | director |
| ALXN | Alexion Pharmaceuticals Inc | 2017-05-10 | director |
| MX | MagnaChip Semiconductor Corp | 2016-03-11 | director |
 | | 2013-09-15 | director |
| | 2009-11-20 | other: Nominee to Board of Directors |
R Douglas Norby Latest Holdings Summary
R Douglas Norby currently owns a total of 2 stocks. Among these stocks, R Douglas Norby owns 32,481 shares of Alexion Pharmaceuticals Inc (ALXN) as of December 11, 2015, with a value of $6 Million and a weighting of 77.86%. R Douglas Norby also owns 9,000 shares of Krystal Biotech Inc (KRYS) as of May 9, 2018, with a value of $2 Million and a weighting of 22.14%.
Latest Holdings of R Douglas Norby
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALXN | Alexion Pharmaceuticals Inc | 2015-12-11 | 32,481 | 182.50 | 5,927,783 |
| KRYS | Krystal Biotech Inc | 2018-05-09 | 9,000 | 187.28 | 1,685,520 |
Holding Weightings of R Douglas Norby
R Douglas Norby Form 4 Trading Tracker
According to the SEC Form 4 filings, R Douglas Norby has made a total of 0 transactions in Alexion Pharmaceuticals Inc (ALXN) over the past 5 years. The most-recent trade in Alexion Pharmaceuticals Inc is the sale of 45,442 shares on December 11, 2015, which brought R Douglas Norby around $9 Million.
According to the SEC Form 4 filings, R Douglas Norby has made a total of 0 transactions in Krystal Biotech Inc (KRYS) over the past 5 years. The most-recent trade in Krystal Biotech Inc is the acquisition of 9,000 shares on May 9, 2018, which cost R Douglas Norby around $93,780.
Insider Trading History of R Douglas Norby
- 1
R Douglas Norby Trading Performance
GuruFocus tracks the stock performance after each of R Douglas Norby's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by R Douglas Norby is 60.1%. GuruFocus also compares R Douglas Norby's trading performance to market benchmark return within the same time period. The performance of stocks bought by R Douglas Norby within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how R Douglas Norby's insider trading performs compared to the benchmark.
Performance of R Douglas Norby
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 38.1 | | | | | |
| Relative Return to S&P 500(%) | 35.09 | | | | | |
R Douglas Norby Ownership Network
Ownership Network List of R Douglas Norby
Ownership Network Relation of R Douglas Norby
R Douglas Norby Owned Company Details
What does Krystal Biotech Inc do?
Who are the key executives at Krystal Biotech Inc?
R Douglas Norby is the director of Krystal Biotech Inc. Other key executives at Krystal Biotech Inc include director & 10 percent owner & President and CEO Krish S Krishnan , director & 10 percent owner & Chief Operating Officer Suma Krishnan , and Chief Accounting Officer Kathryn Romano .
Krystal Biotech Inc (KRYS) Insider Trades Summary
Over the past 18 months, R Douglas Norby made no insider transaction in Krystal Biotech Inc (KRYS). Other recent insider transactions involving Krystal Biotech Inc (KRYS) include a net sale of 300,000 shares made by Suma Krishnan , a net sale of 300,000 shares made by Krish S Krishnan , and a net sale of 76,515 shares made by Kathryn Romano .
In summary, during the past 3 months, insiders sold 100,000 shares of Krystal Biotech Inc (KRYS) in total and bought 0 shares, with a net sale of 100,000 shares. During the past 18 months, 809,015 shares of Krystal Biotech Inc (KRYS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 809,015 shares.
Krystal Biotech Inc (KRYS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Krystal Biotech Inc Insider Transactions
R Douglas Norby Mailing Address
Above is the net worth, insider trading, and ownership report for R Douglas Norby. You might contact R Douglas Norby via mailing address: C/o Magnachip Semiconductor, Inc., 20400 Stevens Creek Boulevard, Suite 370, Cupertino Ca 95014.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
